| scholarly article | Q13442814 |
| P50 | author | Mohammad Bakhriansyah | Q87736071 |
| P2093 | author name string | Anthonius de Boer | |
| Olaf H Klungel | |||
| Patrick C Souverein | |||
| Ronald H B Meyboom | |||
| P2860 | cites work | Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDS and Cox 2 inhibitors | Q71799101 |
| Cyclooxygenase selectivity and the risk of gastro-intestinal complications of various non-steroidal anti-inflammatory drugs: a clinical consideration | Q77609053 | ||
| Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident | Q80085198 | ||
| Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death | Q81239948 | ||
| Nonsteroidal anti-inflammatory drug hypersensitivity: not always an allergy! | Q95482939 | ||
| Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis | Q24646764 | ||
| Association between bone mineral density and the use of nonsteroidal anti-inflammatory drugs and aspirin: impact of cyclooxygenase selectivity | Q28165861 | ||
| Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib | Q28168018 | ||
| Rofecoxib, as a safe alternative for acetyl salicylic acid/nonsteroidal anti-inflammatory drug-intolerant patients | Q28196392 | ||
| Disproportionality analysis of buprenorphine transdermal system and cardiac arrhythmia using FDA and WHO postmarketing reporting system data. | Q31149096 | ||
| Absence of Cross-Reactivity between Sulfonamide Antibiotics and Sulfonamide Nonantibiotics | Q34271822 | ||
| Safety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease. | Q34474985 | ||
| Use of dipeptidyl peptidase-4 inhibitors and the reporting of infections: a disproportionality analysis in the World Health Organization VigiBase | Q34507149 | ||
| Epidemiology of self-reported drug-induced immediate-type hypersensitivity reactions in the surgical population: a 5-year single-center survey in a romanian allergo-anaesthesia center | Q35713988 | ||
| Risk of hospitalization for angio-oedema among users of newer COX-2 selective inhibitors and other nonsteroidal anti-inflammatory drugs | Q35827826 | ||
| Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review | Q35928690 | ||
| Sulfonamide allergy and cross-reactivity | Q36823136 | ||
| The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database | Q37076419 | ||
| The Weber effect and the United States Food and Drug Administration's Adverse Event Reporting System (FAERS): analysis of sixty-two drugs approved from 2006 to 2010. | Q37683523 | ||
| Impact of safety-related regulatory action on clinical practice: a systematic review. | Q38000336 | ||
| Sulfonamide cross-reactivity: is there evidence to support broad cross-allergenicity? | Q38128763 | ||
| Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis | Q38760114 | ||
| Angioedema associated with nonsteroidal anti-inflammatory drugs | Q38881681 | ||
| Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001). | Q42663513 | ||
| Safety of meloxicam in patients with aspirin/non-steroidal anti-inflammatory drug-induced urticaria and angioedema | Q42840344 | ||
| Safety of parecoxib in patients with nonsteroidal anti-inflammatory drug-induced urticaria or angioedema | Q43592628 | ||
| Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions | Q43746607 | ||
| Different risks for NSAID-induced anaphylaxis | Q43869915 | ||
| Identification of sulfonamide-like adverse drug reactions to celecoxib in the World Health Organization database | Q43921096 | ||
| Celecoxib, safe in NSAID intolerance | Q44163615 | ||
| NSAID-sensitive patients tolerate rofecoxib | Q44237232 | ||
| NSAID-induced urticaria/angioedema does not evolve into chronic urticaria: a 12-year follow-up study | Q45744669 | ||
| The impact of age and sex on the reporting of cough and angioedema with renin-angiotensin system inhibitors: a case/noncase study in VigiBase. | Q48306249 | ||
| Time for more clinical research on non-steroidal anti-inflammatory drug-induced urticaria/angioedema and anaphylaxis. | Q54391391 | ||
| Cyclooxygenase-1 and Cyclooxygenase-2 Selectivity of Widely Used Nonsteroidal Anti-Inflammatory Drugs | Q57480336 | ||
| Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database | Q60619152 | ||
| Value of the clinical history in the diagnosis of urticaria/angioedema induced by NSAIDs with cross-intolerance | Q62129898 | ||
| The effect of indication on hypersensitivity reactions associated with zomepirac sodium and other nonsteroidal antiinflammatory drugs | Q68201925 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 589-600 | |
| P577 | publication date | 2019-04-22 | |
| P1433 | published in | Fundamental and Clinical Pharmacology | Q15760364 |
| P1476 | title | Cyclo-oxygenase selectivity and chemical groups of nonsteroidal anti-inflammatory drugs and the frequency of reporting hypersensitivity reactions: a case/noncase study in VigiBase | |
| P478 | volume | 33 |
Search more.